Skip to main navigation Skip to search Skip to main content

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

  • David W. Eyre*
  • , Nicholas D. Sanderson
  • , Emily Lord
  • , Natasha Regisford-Reimmer
  • , Kevin Chau
  • , Leanne Barker
  • , Markus Morgan
  • , Robert Newnham
  • , Daniel Golparian
  • , Magnus Unemo
  • , Derrick W. Crook
  • , Tim E.A. Peto
  • , Gwenda Hughes
  • , Michelle Cole
  • , Helen Fifer
  • , Anne Edwards
  • , Monique I. Andersson
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

300 Citations (Scopus)

Abstract

We describe a gonorrhoea case with combined high-level azithromycin resistance and ceftriaxone resistance. In February 2018, a heterosexual male was diagnosed with gonorrhoea in the United Kingdom following sexual intercourse with a locally resident female in Thailand and failed treatment with ceftriaxone plus doxycycline and subsequently spectinomycin. Resistance arose from two mechanisms combining for the first time in a genetic background similar to a commonly circulating strain. Urgent action is essential to prevent further spread.

Original languageEnglish
Article number1800323
JournalEurosurveillance
Volume23
Issue number27
DOIs
Publication statusPublished - 5 Jul 2018

Bibliographical note

Publisher Copyright:
© 2018, European Centre for Disease Prevention and Control (ECDC). All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018'. Together they form a unique fingerprint.

Cite this